Brief: HeartBeam Will Not Build Large Commercial Organization For Arrhythmia Indication
Brief: Heartbeam, Inc. Enters Into At-The-Market Equity Offering Sales Agreement For Up To $25 Million In Common Stock
HeartBeam, Inc. reports results for the quarter ended June 30 - Earnings Summary
HeartBeam Q2 loss per share narrows; co lowers FY net operating cash outflow guidance
HeartBeam, Inc. expected to post a loss of 9 cents a share - Earnings Preview
Brief: Heartbeam Announces Strategic Shift To Accelerate Global Adoption Of Its Ambulatory ECG Signal Platform And Leadership Transition
Brief: Heartbeam Reports First Quarter 2026 Results
HeartBeam Q1 net loss narrows as commercialization advances
Brief: Heartbeam Initiates Pilot Study Of First On-Demand 12-Lead ECG Patch To Detect Ischemia Outside The Clinic
Brief: Heartbeam Expands Commercial Presence Across Four Key U.S. Markets With Addition Of Premier Concierge Practice
Brief: Heartbeam Announces Closing Of $10 Million Public Offering Of Common Stock
Brief: Heartbeam Announces Proposed Public Offering Of Common Stock
HeartBeam Q4 net loss widens
Brief: HeartBeam FY Operating Expenses USD 21.139 Million
U.S. STOCKS ON THE MOVE-Nuwellis, Citigroup, Meta
U.S. STOCKS ON THE MOVE-GE Vernova, Atlas Energy, Citigroup
U.S. STOCKS ON THE MOVE-Rivian, Bunge, Vertex
U.S. STOCKS ON THE MOVE-Crypto stocks, MiNK Therapeutics, AtaiBeckley
HeartBeam rises after unveiling AI heart‑monitoring partnership